Menopause Surgical
9
1
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Hormonal Regulation of Cardiometabolic Health Study
Acupuncture With/Without Self-acupressure for Post-oophorectomy Hot Flashes in BRCA Carriers
Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause
Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity
RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity
Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause
The Role of Estrogen in Adipocyte Remodeling Following Surgical Menopause
Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause
Health After eaRly Menopause Due to Oophorectomy